EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation

Luxin Zhang, Shaoyue Li, Feiqing Wang, Yun Zhan, Weiwei Cheng, Mei Zhao, Peng Zhao, Wen Xu, Yi Huang, Xueying Yang, Tianzhuo Zhang, Yanju Li und 2 weitere

Annals of Hematology · 10.11.2026

DOI: 10.1007/s00277-026-07341-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 10.11.2026. Verfasst von Luxin Zhang und 13 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Subject Excellent Reserve Talent Project, Clinical Key Specialty Project of Guizhou Province, Clinical Medicine Research Center of Guizhou Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After allogeneic hematopoietic stem cell transplantation (allo-HSCT), some patients continue to have severe anemia despite neutrophil and platelet engraftment, and persistent poor erythroid recovery often leaves them dependent on red blood cell transfusion. Management in this setting remains difficult. To examine the clinical activity of luspatercept in patients with anemia related to poor erythroid engraftment after allo-HSCT, focusing on hemoglobin (Hb) recovery, transfusion outcomes, and changes in bone marrow erythropoiesis. We retrospectively reviewed 12 patients treated at our center between January 2023 and December 2025 for anemia related to poor erythroid engraftment after allo-HSCT. All had achieved myeloid and megakaryocytic engraftment and complete donor chimerism confirmed by short tandem repeat analysis, but their peripheral blood Hb remained

Förderung

  • the Subject Excellent Reserve Talent Project
  • Clinical Key Specialty Project of Guizhou Province
  • Clinical Medicine Research Center of Guizhou Province
  • the Foundation of Hematology Specialization
  • Natural Science Foundation of Guizhou Province

Zitieren

APA

Zhang, L., Li, S., Wang, F., Zhan, Y., Cheng, W., Zhao, M., Zhao, P., Xu, W., Huang, Y., Yang, X., Zhang, T., Li, Y., Liu, Y., & Zhu, H. (2026). Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. https://doi.org/10.1007/s00277-026-07341-1

Vancouver

Zhang L, Li S, Wang F, Zhan Y, Cheng W, Zhao M, et al. Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 2026. doi:10.1007/s00277-026-07341-1

BibTeX
@article{Zhang2026,
  author = {Zhang, Luxin and Li, Shaoyue and Wang, Feiqing and Zhan, Yun and Cheng, Weiwei and Zhao, Mei and Zhao, Peng and Xu, Wen and Huang, Yi and Yang, Xueying and Zhang, Tianzhuo and Li, Yanju and Liu, Yang and Zhu, Hongqian},
  title = {Clinical activity of luspatercept in patients with poor erythroid engraftment after allogeneic hematopoietic stem cell transplantation},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-07341-1}
}
Kostenlos starten →